Análisis de costo efectividad de ondansetrón para el tratamiento del vómito en niños menores de cinco años con gastroenteritis en Colombia

ABSTRACT: Introduction: Ondansetron reduces hospitalization rates for diarrhea and vomiting in children, but is not yet routinely used. Objective: To estimate from a social perspective the relative cost-effectiveness of ondansetron for the treatment of vomiting in children with gastroenteritis and a...

Full description

Autores:
Atehortúa Becerra, Sara Catalina
Flórez Gómez, Iván Darío
Ceballos González, Mateo
Granados Rugeles, Claudia Marcela
Orozco Ramírez, Luis Esteban
Mejía Mejía, Aurelio Enrique
Tipo de recurso:
Article of investigation
Fecha de publicación:
2015
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
spa
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/44696
Acceso en línea:
https://hdl.handle.net/10495/44696
Palabra clave:
Vómitos
Vomiting
Gastroenteritis
Colombia
Diarrea
Diarrhea
Ondansetrón
Ondansetron
Análisis de Costo-Efectividad
Cost-Effectiveness Analysis
Hospitalización
Hospitalization
Niño
Child
https://id.nlm.nih.gov/mesh/D003967
https://id.nlm.nih.gov/mesh/D014839
https://id.nlm.nih.gov/mesh/D005759
https://id.nlm.nih.gov/mesh/D017294
https://id.nlm.nih.gov/mesh/D003105
https://id.nlm.nih.gov/mesh/D000094703
https://id.nlm.nih.gov/mesh/D006760
https://id.nlm.nih.gov/mesh/D002648
Rights
openAccess
License
https://creativecommons.org/licenses/by-nc-nd/4.0/
id UDEA2_a7fd73de01865fa342fa0a29c7bcd6f8
oai_identifier_str oai:bibliotecadigital.udea.edu.co:10495/44696
network_acronym_str UDEA2
network_name_str Repositorio UdeA
repository_id_str
dc.title.spa.fl_str_mv Análisis de costo efectividad de ondansetrón para el tratamiento del vómito en niños menores de cinco años con gastroenteritis en Colombia
title Análisis de costo efectividad de ondansetrón para el tratamiento del vómito en niños menores de cinco años con gastroenteritis en Colombia
spellingShingle Análisis de costo efectividad de ondansetrón para el tratamiento del vómito en niños menores de cinco años con gastroenteritis en Colombia
Vómitos
Vomiting
Gastroenteritis
Colombia
Diarrea
Diarrhea
Ondansetrón
Ondansetron
Análisis de Costo-Efectividad
Cost-Effectiveness Analysis
Hospitalización
Hospitalization
Niño
Child
https://id.nlm.nih.gov/mesh/D003967
https://id.nlm.nih.gov/mesh/D014839
https://id.nlm.nih.gov/mesh/D005759
https://id.nlm.nih.gov/mesh/D017294
https://id.nlm.nih.gov/mesh/D003105
https://id.nlm.nih.gov/mesh/D000094703
https://id.nlm.nih.gov/mesh/D006760
https://id.nlm.nih.gov/mesh/D002648
title_short Análisis de costo efectividad de ondansetrón para el tratamiento del vómito en niños menores de cinco años con gastroenteritis en Colombia
title_full Análisis de costo efectividad de ondansetrón para el tratamiento del vómito en niños menores de cinco años con gastroenteritis en Colombia
title_fullStr Análisis de costo efectividad de ondansetrón para el tratamiento del vómito en niños menores de cinco años con gastroenteritis en Colombia
title_full_unstemmed Análisis de costo efectividad de ondansetrón para el tratamiento del vómito en niños menores de cinco años con gastroenteritis en Colombia
title_sort Análisis de costo efectividad de ondansetrón para el tratamiento del vómito en niños menores de cinco años con gastroenteritis en Colombia
dc.creator.fl_str_mv Atehortúa Becerra, Sara Catalina
Flórez Gómez, Iván Darío
Ceballos González, Mateo
Granados Rugeles, Claudia Marcela
Orozco Ramírez, Luis Esteban
Mejía Mejía, Aurelio Enrique
dc.contributor.author.none.fl_str_mv Atehortúa Becerra, Sara Catalina
Flórez Gómez, Iván Darío
Ceballos González, Mateo
Granados Rugeles, Claudia Marcela
Orozco Ramírez, Luis Esteban
Mejía Mejía, Aurelio Enrique
dc.contributor.researchgroup.spa.fl_str_mv Economía de la Salud
Grupo de Investigación Clínica en Enfermedades del Niño y del Adolescente - Pediaciencias
Rehabilitación en Salud
dc.subject.decs.none.fl_str_mv Vómitos
Vomiting
Gastroenteritis
Colombia
Diarrea
Diarrhea
Ondansetrón
Ondansetron
Análisis de Costo-Efectividad
Cost-Effectiveness Analysis
Hospitalización
Hospitalization
Niño
Child
topic Vómitos
Vomiting
Gastroenteritis
Colombia
Diarrea
Diarrhea
Ondansetrón
Ondansetron
Análisis de Costo-Efectividad
Cost-Effectiveness Analysis
Hospitalización
Hospitalization
Niño
Child
https://id.nlm.nih.gov/mesh/D003967
https://id.nlm.nih.gov/mesh/D014839
https://id.nlm.nih.gov/mesh/D005759
https://id.nlm.nih.gov/mesh/D017294
https://id.nlm.nih.gov/mesh/D003105
https://id.nlm.nih.gov/mesh/D000094703
https://id.nlm.nih.gov/mesh/D006760
https://id.nlm.nih.gov/mesh/D002648
dc.subject.meshuri.none.fl_str_mv https://id.nlm.nih.gov/mesh/D003967
https://id.nlm.nih.gov/mesh/D014839
https://id.nlm.nih.gov/mesh/D005759
https://id.nlm.nih.gov/mesh/D017294
https://id.nlm.nih.gov/mesh/D003105
https://id.nlm.nih.gov/mesh/D000094703
https://id.nlm.nih.gov/mesh/D006760
https://id.nlm.nih.gov/mesh/D002648
description ABSTRACT: Introduction: Ondansetron reduces hospitalization rates for diarrhea and vomiting in children, but is not yet routinely used. Objective: To estimate from a social perspective the relative cost-effectiveness of ondansetron for the treatment of vomiting in children with gastroenteritis and at risk of dehydration in Colombia. Methods: Cost-effectiveness analysis from a social perspective, including direct medical costs and costs for caregivers. With a decision tree we compared costs and health outcomes of usual treatment without antiemetic to usual treatment plus ondansetron in children under 5 years with gastroenteritis and vomiting. Effectiveness of intervention was measured as reduction in hospitalization rates, and the time horizon of the model was the episode. Probabilities were obtained from clinical trials and systematic reviews, measurement of resources use was based on protocols and expert opinions, while unit costs were obtained from Colombian tariff manuals. We performed a survey to estimate indirect costs for caregivers (n=81) that included questions about wage loss, transportation, meals expenditures and other out-of-pocket payments. Deterministic and probabilistic sensitivity analyses were performed. Results: Usual treatment plus ondansetron is a dominant strategy compared to usual treatment without antiemetic yielding fewer hospitalizations and saving $44.562 Colombian pesos (23,98USD) per episode. Ondansetron was dominant in 98,91% of simulations of the probabilistic analysis. Conclusions: Ondansetron is a dominant intervention that reduces hospitalization rates and costs for health system and caregivers. We recommend assessing the inclusion of this drug in the Colombian Health Benefit Plan for the treatment of gastroenteritis in children under 5 years.
publishDate 2015
dc.date.issued.none.fl_str_mv 2015
dc.date.accessioned.none.fl_str_mv 2025-02-05T13:49:02Z
dc.date.available.none.fl_str_mv 2025-02-05T13:49:02Z
dc.type.spa.fl_str_mv Artículo de investigación
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.redcol.spa.fl_str_mv https://purl.org/redcol/resource_type/ART
dc.type.coarversion.spa.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.driver.spa.fl_str_mv info:eu-repo/semantics/article
dc.type.version.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
format http://purl.org/coar/resource_type/c_2df8fbb1
status_str publishedVersion
dc.identifier.citation.spa.fl_str_mv Atehortúa S, Flórez ID, Ceballos M, Granados C, Orozco LE, Mejía A. Análisis de costo efectividad de ondansetrón para el tratamiento del vómito en niños menores de cinco años con gastroenteritis en Colombia. Value Health Reg Issues. 2015 Dec;8:1-7. Spanish.
dc.identifier.issn.none.fl_str_mv 2212-1099
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/10495/44696
dc.identifier.doi.none.fl_str_mv 10.1016/j.vhri.2014.11.001
dc.identifier.eissn.none.fl_str_mv 2212-1102
identifier_str_mv Atehortúa S, Flórez ID, Ceballos M, Granados C, Orozco LE, Mejía A. Análisis de costo efectividad de ondansetrón para el tratamiento del vómito en niños menores de cinco años con gastroenteritis en Colombia. Value Health Reg Issues. 2015 Dec;8:1-7. Spanish.
2212-1099
10.1016/j.vhri.2014.11.001
2212-1102
url https://hdl.handle.net/10495/44696
dc.language.iso.spa.fl_str_mv spa
language spa
dc.relation.ispartofjournalabbrev.spa.fl_str_mv Value. Health. Reg. Issues.
dc.relation.citationendpage.spa.fl_str_mv 7
dc.relation.citationstartpage.spa.fl_str_mv 1
dc.relation.citationvolume.spa.fl_str_mv 8
dc.relation.ispartofjournal.spa.fl_str_mv Value in Health Regional Issues
dc.rights.uri.spa.fl_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights.uri.*.fl_str_mv http://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.rights.accessrights.spa.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.coar.spa.fl_str_mv http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/
http://creativecommons.org/licenses/by-nc-nd/2.5/co/
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.extent.spa.fl_str_mv 7 páginas
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Elsevier
dc.publisher.place.spa.fl_str_mv Nueva York, Estados Unidos
institution Universidad de Antioquia
bitstream.url.fl_str_mv https://bibliotecadigital.udea.edu.co/bitstreams/e9c3961b-985a-4b4a-b365-3f7e049eb2a1/download
https://bibliotecadigital.udea.edu.co/bitstreams/7476c4e3-54ee-402d-83be-38f2678c0fae/download
https://bibliotecadigital.udea.edu.co/bitstreams/a9c410d5-be89-4a5a-8731-284d70275adc/download
https://bibliotecadigital.udea.edu.co/bitstreams/be0f867c-aad8-435a-9365-f0d2e8aaba4e/download
https://bibliotecadigital.udea.edu.co/bitstreams/38902543-6c72-4ba5-aeaa-7916f182638d/download
bitstream.checksum.fl_str_mv b88b088d9957e670ce3b3fbe2eedbc13
8a4605be74aa9ea9d79846c1fba20a33
d09f4d5eb7e12e77cb713db057762a58
0d606470184554f63d8e2ef33e12ae14
640aac5cae173aa0b6b9b17b4e265fa9
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional de la Universidad de Antioquia
repository.mail.fl_str_mv aplicacionbibliotecadigitalbiblioteca@udea.edu.co
_version_ 1851052539684847616
spelling Atehortúa Becerra, Sara CatalinaFlórez Gómez, Iván DaríoCeballos González, MateoGranados Rugeles, Claudia MarcelaOrozco Ramírez, Luis EstebanMejía Mejía, Aurelio EnriqueEconomía de la SaludGrupo de Investigación Clínica en Enfermedades del Niño y del Adolescente - PediacienciasRehabilitación en Salud2025-02-05T13:49:02Z2025-02-05T13:49:02Z2015Atehortúa S, Flórez ID, Ceballos M, Granados C, Orozco LE, Mejía A. Análisis de costo efectividad de ondansetrón para el tratamiento del vómito en niños menores de cinco años con gastroenteritis en Colombia. Value Health Reg Issues. 2015 Dec;8:1-7. Spanish.2212-1099https://hdl.handle.net/10495/4469610.1016/j.vhri.2014.11.0012212-1102ABSTRACT: Introduction: Ondansetron reduces hospitalization rates for diarrhea and vomiting in children, but is not yet routinely used. Objective: To estimate from a social perspective the relative cost-effectiveness of ondansetron for the treatment of vomiting in children with gastroenteritis and at risk of dehydration in Colombia. Methods: Cost-effectiveness analysis from a social perspective, including direct medical costs and costs for caregivers. With a decision tree we compared costs and health outcomes of usual treatment without antiemetic to usual treatment plus ondansetron in children under 5 years with gastroenteritis and vomiting. Effectiveness of intervention was measured as reduction in hospitalization rates, and the time horizon of the model was the episode. Probabilities were obtained from clinical trials and systematic reviews, measurement of resources use was based on protocols and expert opinions, while unit costs were obtained from Colombian tariff manuals. We performed a survey to estimate indirect costs for caregivers (n=81) that included questions about wage loss, transportation, meals expenditures and other out-of-pocket payments. Deterministic and probabilistic sensitivity analyses were performed. Results: Usual treatment plus ondansetron is a dominant strategy compared to usual treatment without antiemetic yielding fewer hospitalizations and saving $44.562 Colombian pesos (23,98USD) per episode. Ondansetron was dominant in 98,91% of simulations of the probabilistic analysis. Conclusions: Ondansetron is a dominant intervention that reduces hospitalization rates and costs for health system and caregivers. We recommend assessing the inclusion of this drug in the Colombian Health Benefit Plan for the treatment of gastroenteritis in children under 5 years.Universidad de Antioquia. Facultad de Ciencias Económicas. Centro de Investigaciones y Consultorías –CIC. Grupo de Economía de la SaludCOL0015599COL0058784COL00040597 páginasapplication/pdfspaElsevierNueva York, Estados Unidoshttps://creativecommons.org/licenses/by-nc-nd/4.0/http://creativecommons.org/licenses/by-nc-nd/2.5/co/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2Análisis de costo efectividad de ondansetrón para el tratamiento del vómito en niños menores de cinco años con gastroenteritis en ColombiaArtículo de investigaciónhttp://purl.org/coar/resource_type/c_2df8fbb1https://purl.org/redcol/resource_type/ARThttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionVómitosVomitingGastroenteritisColombiaDiarreaDiarrheaOndansetrónOndansetronAnálisis de Costo-EfectividadCost-Effectiveness AnalysisHospitalizaciónHospitalizationNiñoChildhttps://id.nlm.nih.gov/mesh/D003967https://id.nlm.nih.gov/mesh/D014839https://id.nlm.nih.gov/mesh/D005759https://id.nlm.nih.gov/mesh/D017294https://id.nlm.nih.gov/mesh/D003105https://id.nlm.nih.gov/mesh/D000094703https://id.nlm.nih.gov/mesh/D006760https://id.nlm.nih.gov/mesh/D002648Value. Health. Reg. Issues.718Value in Health Regional IssuesEstrategia de Sostenibilidad 2011-2012RoR:03bp5hc83PublicationCC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8823https://bibliotecadigital.udea.edu.co/bitstreams/e9c3961b-985a-4b4a-b365-3f7e049eb2a1/downloadb88b088d9957e670ce3b3fbe2eedbc13MD52falseAnonymousREADLICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://bibliotecadigital.udea.edu.co/bitstreams/7476c4e3-54ee-402d-83be-38f2678c0fae/download8a4605be74aa9ea9d79846c1fba20a33MD53falseAnonymousREADORIGINALAtehortuaSara_2015_Analisis_Costo_Efectividad_Ondansetron.pdfAtehortuaSara_2015_Analisis_Costo_Efectividad_Ondansetron.pdfArtículo de investigaciónapplication/pdf735403https://bibliotecadigital.udea.edu.co/bitstreams/a9c410d5-be89-4a5a-8731-284d70275adc/downloadd09f4d5eb7e12e77cb713db057762a58MD51trueAnonymousREADTEXTAtehortuaSara_2015_Analisis_Costo_Efectividad_Ondansetron.pdf.txtAtehortuaSara_2015_Analisis_Costo_Efectividad_Ondansetron.pdf.txtExtracted texttext/plain45880https://bibliotecadigital.udea.edu.co/bitstreams/be0f867c-aad8-435a-9365-f0d2e8aaba4e/download0d606470184554f63d8e2ef33e12ae14MD54falseAnonymousREADTHUMBNAILAtehortuaSara_2015_Analisis_Costo_Efectividad_Ondansetron.pdf.jpgAtehortuaSara_2015_Analisis_Costo_Efectividad_Ondansetron.pdf.jpgGenerated Thumbnailimage/jpeg16514https://bibliotecadigital.udea.edu.co/bitstreams/38902543-6c72-4ba5-aeaa-7916f182638d/download640aac5cae173aa0b6b9b17b4e265fa9MD55falseAnonymousREAD10495/44696oai:bibliotecadigital.udea.edu.co:10495/446962025-03-27 00:01:35.014https://creativecommons.org/licenses/by-nc-nd/4.0/open.accesshttps://bibliotecadigital.udea.edu.coRepositorio Institucional de la Universidad de Antioquiaaplicacionbibliotecadigitalbiblioteca@udea.edu.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